Cisco Systems Inc. (NASDAQ: CSCO) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.08 billion. On Thursday shares of Cisco Systems, Inc. (NASDAQ:CSCO) closed at $29.46. Company’s sales growth for last 5 years was 5.50% and EPS growth for next 5 years is recorded as 7.64%.
Johnson & Johnson (NYSE:JNJ) has dropped its request to investigate the source of what it said were illegal phone calls that may have resulted in baseless lawsuits over transvaginal mesh devices against its Ethicon Inc subsidiary. Johnson & Johnson (NYSE:JNJ) in last trading activity moved down -1.93% to close at $98.44. Company weekly performance is -3.92% while its quarterly performance stands at -9.03%. Johnson & Johnson (NYSE:JNJ) is -9.68% away from its 52 week high.
On 4 February, Merck & Co. Inc. (NYSE:MRK) announced Fourth-Quarter 2014 Non-GAAP EPS of $0.87, Excluding Certain Items; GAAP EPS of $2.54; Full-Year 2014 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $4.07. On last trading day Merck & Co. Inc. (NYSE:MRK) advanced 0.24% to close at $58.88. Its volatility for the week is 1.34% while volatility for the month is 1.85%. MRK’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was -16.50%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -5.32%.
Hospira Inc. (NYSE:HSP) reported upbeat earnings for the fourth quarter. The Lake Forest, Illinois-based company reported a quarterly profit of $35.8 million, or $0.21 per share, versus a year-ago profit of $33.5 million, or $0.20 per share. Excluding items, the company earned $0.53 per share. Hospira Inc. (NYSE:HSP) has 0.20% insider ownership while its institutional ownership stands at 92.90%. In last trading activity company’s stock closed at $87.35.
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price objective lowered by JPMorgan Chase & Co. from $53.00 to $47.00 in a research report released on Friday morning. JPMorgan Chase & Co. currently has an overweight rating on the stock. On last trading day Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) moved down -1.72% to close at $33.74. Its volatility for the week is 4.99% while volatility for the month is 5.32%. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) monthly performance is -30.73%.